Associated Banc-Corp (ASB)
Associated Banc-Corp (ASB) Stock Price, Analysis & Data
Нет данных
| Бид | 30.37 |
| Рыночная капитализация | 5.81B |
| Выручка (TTM) | 1.56B |
| Чистая прибыль (TTM) | 491.64M |
| Бета | 0.77 |
| EPS (TTM) | 2.85 |
| P/E (TTM) | 10.79 |
| Прогнозный P/E | 9.24 |
| P/B (TTM) | 1.05 |
| P/S (TTM) | 3.73 |
| Earnings Date | Oct 22, 2026 |
| Аск | 31.09 |
| Объём торгов | 1,186,717 |
| Ср. объём (20д) | 1,974,196 |
| Открытие | 30.66 |
| Пред. закрытие | 30.81 |
| Диапазон дня | 30.59 - 30.91 |
| Диапазон за 52 недели | 23.86 - 32.46 |
| Аналитики | Buy |
| Целевая цена | 34 (10.53%) |
| Дивиденды | $0.96 (3.12%) |
| Дата отсечки | 1 сент. 2026 г. |
О компании ASB
Associated Banc-Corp, a bank holding company, provides various banking and nonbanking products and services to individuals and businesses in Wisconsin, Illinois, Missouri, Texas, and Minnesota. It offers lending solutions, including commercial loans and lines of credit, commercial real estate financing, construction loans, letters of credit, leasing, asset-based lending and equipment finance, loan syndications products, residential mortgages, hom...
Финансовые результаты
В 2025 году выручка Associated Banc-Corp составила 1.48B — это рост на 43.71% к прошлогодним 1.03B. Прибыль составила 474.78M — это рост на 285.54%.
Финансовая отчётностьПрогноз аналитиков
По 9 оценкам аналитиков средний рейтинг акций ASB — «Buy». Прогноз цены на 12 месяцев — 34, это потенциал роста на 10.53% от последней цены.
Прогнозы по акцииСюрприз в отчёте
Аналитики ждут выручку ... Улучшить тариф
3 недель назад · Simply Wall St.
Associated Banc Corp (ASB) Could Be 8% Undervalued As 2026 Guidance RisesAssociated Banc-Corp (ASB) stock is in focus after the company raised its 2026 guidance alongside its second quarter earnings, highlighting higher net interest and non interest income following the Am...
3 недель назад · Simply Wall St.
Associated Banc Corp (ASB) Stock May Be A Bargain On Lasting ValueAssociated Banc-Corp stock has almost doubled over the past five years, yet its current price of US$30.81 still screens as cheap against an intrinsic value estimate from the Excess Returns model and c...